Lin BioScience, Inc. (TPEX:6696)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
389.00
-10.50 (-2.63%)
Mar 9, 2026, 2:00 PM CST

Lin BioScience Market Cap

Lin BioScience has a market cap or net worth of 32.26 billion as of March 9, 2026. Its market cap has increased by 182.97% in one year.

Market Cap
32.26B
Enterprise Value
29.58B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
389.00

Market Cap Chart

Since October 8, 2018, Lin BioScience's market cap has increased from 2.92B to 32.26B, an increase of 1,006.37%. That is a compound annual growth rate of 38.30%.

History

DateMarket Cap% Change
Mar 6, 202633.05B0.63%
Dec 31, 202532.84B203.76%
Dec 31, 202410.81B20.85%
Dec 29, 20238.95B-28.90%
Dec 30, 202212.58B-1.94%
Dec 30, 202112.83B83.66%
Dec 31, 2020 Pro Pro
Dec 31, 2019 Pro Pro
Dec 28, 2018 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Pell Bio-Med Technology 36.42B
Lumosa Therapeutics 27.12B
Oneness Biotech 26.27B
Polaris Group 23.58B
Sunmax Biotechnology 21.21B
EirGenix 18.10B
TaiMed Biologics 14.62B
AP Biosciences 14.46B
Market Cap Rankings